Project Details
Project Description
Stroke is a crippling disease with very few treatment options. Nano-sized packages released by stem cells called exosomes contain signalling molecules that can initiate repair and regeneration, have anti-inflammatory properties and possess fewer limitations than their parent cell. Thus, exosomes offer great therapeutic hope for stroke patients. This project will test whether exosomes isolated from human placenta-derived stem cells can improve stroke-induced brain damage and functional impairment.
Short title | Cell free therapy to improve stroke outcomes |
---|---|
Status | Active |
Effective start/end date | 1/01/21 → 31/12/22 |
Funding
- Heart Foundation: A$132,240.00
Keywords
- Stroke
- Exosomes
- inflammation
Equipment
-
Animal Research Platform (MARP)
Tanya Lennane (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility
-
FlowCore
Andrew Fryga (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility
-
Histology Platform
Camilla Cohen (Manager)
Faculty of Medicine Nursing and Health Sciences Research PlatformsFacility/equipment: Facility